Pharmacy Education Newsletter, Issue 1

PE Newsletter | October 2012

International Pharmaceutical Students’ Federation

ISSUE

NO.

1

PEN Pharmacy Education Newsletter

page 1 education@ipsf.org

page 2

PEN editorial Un nouveau dĂŠpart !

A new beggining !

Dearest IPSFers, Today, I have the pleasure to share with you the new IPSF Pharmacy Education Newsletter.

Mr. Marouen Ben Guebila Chairperson of Pharmacy Education 2012-2013

Each month, PE team, including PE subcomitte, PE coordinators and me, will keep you updated about educational and scientific events all around the world, internships opportunities and a selection of relevant pharmacy related articles .

You will find not only articles/reports written by IPSFers who represented our dear Federation in big events in order to share their experience with you, but also, scientific articles selected by PESC or articles written by academicians.

As most of our associations plan every year several educational events, we decided to ask our dear CPs to have a report for such events.

Enjoy !

Marouen

publication team

content Pre-event

ISSUE

NO.

1

Ed Innovation

October 2012

Design & Layout

Ms. Alexandra Marques IPSF Chairperson of Media and Publications

Cover photo

FIP International Pharmaceutical Federation

Proofread by

Mr. Jason Hong publications@ipsf.org editor@ipsf.org

Interns Symposium ASEPA Algeria

Page 3

Page 4

Herbal Tour BEM KMFA UGM Indonesia

Page 6

How to bring drugs to market faster Sir Francis Collin’s Talk at TEDMED 2012 Page 8

PEN pre-event FIP 2012

Centennial Congress In the break of examinations and work, at the beginning of the autumn, it was the right time to be focused on the event of the century in our pharmaceutical world.

This will be an exceptional FIP (International Pharmaceutical Federation) Centennial Congress which will take place in Amsterdam, The Netherlands, during 3rd – 8th October 2012.

Knowing that FIP is celebrating her 100 years anniversary , gives us the great reason to think how we can develop pharmaceutical science, education and practice and how we can give the input to the world’s community and society.

Each of us can have a lot of great ideas on: how to improve studies, work, current projects… But like the saying goes, when you plant one a tree on top of a mountain, probably the strong winds will damage it. It wouldn’t be the case if you plant the a forest instead of the one tree. That is in the nature.

Pharmaceutical networking gives us the extraordinary opportunity to share opinions and ideas with colleagues, ensuring that all our ideas are safe from being forgotten. Therefore, the best opportunity to do so is during FIP Centennial Congress in Amsterdam, where thousands of professionals will be present.

International Pharmaceutical Federation (FIP) is a repository of worldwide pharmaceutical knowledge.

During the Centennial Congress, numerous sessions will be held related to different fields of pharmaceutical practice such as:

page 4

· Academic Pharmacy · Clinical Biology · Community Pharmacy · Hospital Pharmacy · Industrial Pharmacy · Laboratories and Medicines Control · Military and Emergency Pharmacy · Pharmacy Information · Social and Administrative Pharmacy Each field of pharmacy is covered by the educational program of FIP 2012 Centennial Congress and it is up to your personal preferences, what will be the best choice for you to be updated with new information and trends in pharmaceutical practice and science.

I am very glad that I have an opportunity to attend FIP 2012 Centennial Congress in Amsterdam and to follow continuous idea - Advancing pharmacy worldwide.

Mr. Vladimir Obradović

IPSF Chairperson of Internal relations 2010-2011

Reference: 1. International Pharmaceutical Federation (FIP) webpage: www.fip.org

PEN ed innovation

Interns Symposium

The Algerian Experience The initiative was first started by ASEPA Algeria in 2009.

When it was organized for the first time, the objective was to motivate the interns to seek an interesting topic for their project that would be accepted for presentation at the symposium at the end of the year.

The goal behind the Intern’ Symposium is to provide an opportunity for the interns to conduct a scientific research project during their internship. The students would need to define a clear objective for their project and seek to find the evidence to support their findings.

There are two components to the Interns’ Symposium which includes the oral presentation and poster exhibition. During the oral presentation, the intern will introduce his or her project to an audience of professors and fellow interns. The audience will be able to critique and evaluate the project following the presentation. This will be supplemented with the poster exhibition. At the exhibition, the attendees of the symposium are able to speak with the interns personally about their work for the project and this allows the interns to concisely discuss their work with colleagues.

Mr. Redouane Soualmi Immediate Past AfRO Chairperson 2012-13

page 5

PEN ed innovation

Herbal Tour Indonesia

In this modern era, there are so many new drugs are developed for further to be discovered especially synthetics drugs. On the other hand, Indonesia still reserves its culture to use herbal traditional medicine which is developed and manufactured from medicinal plants. This Indonesian traditional medicine is called “jamu�. Most of Indonesian especially the older generation prefer to use Jamu than conventional medication because it’s more affordable, easy to prepare, and has less of side effects. Many years ago people make Jamu on their own by boiling the herbs and then drink it. But now because of the developing science and technology, Jamu are developed, manufactured, and packed in modern dosage form by herbal industries.

We are really interested to visit some of that industries to know the face of Jamu today. In this Herbal Tour, we visited BBPPTOOT and Java Plant with thirty students from Faculty of Pharmacy Universitas Gadjah Mada including two incoming Student Exchange Programme students from United Kingdom and Czech Republic.

We started our journey at 7 AM on July 10th 2012. It took four hours from our faculty to reach BBPPTOOT. BBPPTOOT is the national association of research and development of medicinal plant and traditional medicine. Most of the national research about medicinal plants is conducted there. During the tour we had a chance to know the history of BBPPTOOT and jamu at first, and continued by walking around to visit all laboratories and herbal garden. We could find some medical plants such as Stevia sp, Tinospor crispa, Ficus septica, Echinacea purpurea, etc. We had the opportunity to see the demonstration of how to make Jamu as well. The first step is harvesting the plant from the garden, then choosing the good quality plant, and after that, the plant is dried until it became simplisia before being packed as the last step.

The second place we visited was the Java Plant. Java Plant is the modern industry of basic material specialized in botanical extraction. Their manufacturing concerns in food, beverage, pharmaceutical, nutraceutical, cosmetic

page 6

and agriculture. They have a good position as a natural ingredient manufacturer. We had the opportunity to know the process of making basic ingredient of some product.

The process showed us from the first form of plant until it become another form such as extract, granule, powder or liquid. One of the method used in this industry is extraction with percolation. The raw material is dissolved with a suitable solvent in a container which has some pores on the bottom. Then the expected active compound from the material will drip from the pores. We can proceed it to be a powder by using a spray dryer. The powder form has a better chemical and physical stability.

From this Herbal Tour, we gained precious experiences and knowledge about medicinal plants; how they are processed in the industry, what kind of research has been conducted, what is the current issue about them, etc. We also gained knowledge about how to do an extraction, to store simplisia, and to choose the best simplisia. From this experience we hope in the future we could continue reserving our culture and developing it as a global medicine so that people around the world can use Jamu as a drugs of choice.

Ms. Etsha Luthfia and Ms. Siti Nur Mufyda

Staff of International Affairs Department/ Chairperson of Herbal Tour activity BEM KMFA UGM

herbal tour

page 7

PEN ed innovation

How to bring drugs to Market Faster Sir Francis Collin’s Talk at TEDMED 2012 Introduction Currently, more than 4000 “Molecular” diseases were identified (i.e. Cystic Fibrosis, Progeria ...) but only 200 can be treated. Why? First because most of those diseases are not common, so developing new treatments is not always financially interesting to Pharmaceutical Industries. But the most important reason is thatit can take 14 years of research and the screening of 10,000 compounds to bring one new drug to the market.

genome sequencing. In fact this technique, at present time, became more accessible at lower costs compared to the nineties.

In fact, it is necessary to identify the gene responsible for molecular defection, in order to build the right “key” with the appropriate “shape”. This identification is made easier by human genome sequencing and allows a better understanding of molecular targets and human genome.

Drug Repurposing How to make tvdrug development go faster and be more successful?

Using Technology for drug screening Taking advantage of Technology such as human

page 8

Drug Repurposing is the use of old drugs in new indications. It is popular especially with antibiotics: when germs develop a new drug resistance mechanism, using another type of antibiotic could be very effective. But where can we find these old or

unused drugs? In reality, Pharmaceutical industries create a lot of chemical compounds in order to find only one drug.

Some of them are used, but the majority is stored in “Drug Freezers”. These compounds could be pharmacologically active in other diseases and could be potentially drugs. This way, industries do not need to create a new drug from the begging, they just have to exploit these hidden drugs.

Progeria Hutchinson–Gilford Progeria Syndrome is an extremely rare genetic condition wherein symptoms resembling aspects of aging are manifested at an early age. This molecular disease can now be treated partially. There are no drugs designed especially for Progeria butone of the best drugs treating Progeria is an old drug used for chemotherapy. A lot of famous drugs were not designed at first for the right disease but at the end they were repurposed successfully for other disease.

In-vitro Cell testing Since testing newly discovered drugs on animals is not reliable-drug effects on humans could be different from those on animals- expensive and time-consuming, it would be more interesting to start testing drugs on human cells, which can be particularly efficient with ‘molecular diseases’.

Conclusion It is only through a partnership between government, academia, private sector and patient organization that drugs could be brought faster from the scientist’s bench to the patient’s bedside.

References 1.Francis S Collins-TEDMED 2012 2.Hutchinson-Gilford progeria syndrome; HGPS – PubMed Health.

3.Biostrategyblog.com 4.Bioinfomatics-KalRenganathan Sharma,

page 9

page 10

page 11

International Pharmaceutical Students’ Federation PO BOX 84200 2508 AE Den Haag The Netherlands Tel: +31 70 302 1992 Fax: +31 70 302 1999 Email: ipsf@ipsf.org Website: www.ipsf.org

page 12